UKs NHS Strengths in Cardiovascular Disease Management

Global Health: Cardiovascular Disease (CVD): SWOT Analysis for the UK: The presence of updated preventive measures and nationalised care program for cardiovascular disease (CVD) by UK National health Services are few of the strengths in high-income country such as the UK for the disease. This is because effective and updated preventive measures for CVD in the NHS helps in enhanced early and strategic control for the disease (NHS, 2021; NHS 2019). The other strengths regarding CVD in the UK are the presence of an effective health plan for controlling prevalence of the disease and enhanced presence of multi-disciplinary team in healthcare to manage CVD in patients. This is evident as NHS England has set a plan for CVD in which it intends to prevent more than 150,000 heart attack, stroke and other CVD related issues in the next10 years to lower the prevalence of the disease (NHS, 2019). Moreover, multi-disciplinary team including cardiologist, surgeons, specialist nurses, radiographers, dieticians, psychologist, occupational therapist and others are present in the UK to treat CVD in effective manner (Morton et al., 2018). In the UK, the lack of enhanced implementation of preventive actions for CVD is acting as weakness for management of the disease. This is because without effective implementation of care measure to be made adequately available for all it is leading many patients to be ignored of support need to avoid and manage CVD leading increased prevalence of the disease (Raisi-Estabragh and Petersen, 2020). The other weaknesses include lack of prioritisation of heart health in healthcare budget, health inequalities regarding CVD care services and lack of healthier environment for CVD management in the UK. It is evident as low budget is been allocated in contrast to the economic requirement for promoting heart health in the UK which creating economic issues to effectively contribute finances in promote better measure for enhanced CVD management in the country. Moreover, existence of health inequality in receiving care is seen among social classes and presence of environment for increased drinking and smoking in the UK is hindering CVD management in the country as they are causing hindered management of risk factors leading to the disease expression (Petersen et al., 2015). The opportunities regarding CVD in the UK include presence of nationalised screening program (UK Cardiac Screening policy), enhanced awareness campaign for CVD (NHS awareness campaign), systematic guidelines for management of the disease (NICE guidelines) and action plan to establish enhanced care for people affected by CVD in the UK (hmt-uk.org, 2021). They act as opportunity in controlling CVD in the UK because enhanced awareness educates the people regarding the way to change their behaviour to avoid CVD (hmt-uk.org, 2021; NICE, 2019; NHS, 2017). Moreover, nationalised screening of disease helps in increased diagnosis of the disease and presence of systematic guidelines and actions assist healthcare professionals to have evidence-based support in delivering enhanced quality error-free care for CVD management (NICE, 2019; NHS, 2017). The threats existing for CVD in the UK is increased leading of sedentary life by people, ineffective self-care, lack of following of healthcare guidance for CVD management and ignoring risk of CVD by common people (Said et al., 2018). It is evident as less physical exercise by UK people are executed with hindered intake of medicine for CVD management and inappropriate leading of lifestyle that is causing increase presence of cholesterol, fats, blood sugar and others in the body which are risk factors for increased expression of CVD (Said et al., 2018).

SWOT Analysis for Nigeria: The strength for prevention and management of CVD in low-income country like Nigeria include growing skilled and educated healthcare staffs for CVD management, increased government participation and gradual increase in CVD treatment opportunities (Hendriks et al., 2015). They act as strength because skilled staffs would provide less errored and duplicated care to the CVD affected patients which would promote their well-being and improve scenario of the disease in the country (Oluyombo et al., 2016). Further, government participation along with gradual enhanced increased of updated care measures for CVD would help the care services to reach all people at risk of the disease which was not previously experienced by them that would make the people have enhanced health out of strategic care been received (Oluyombo et al., 2016). In addition, the other strength is cooperative health staff in Nigeria who are trying their best to implement their expertise in improving care for CVD patients so that their suffering regarding health and well-being care be reduced from the disease (Amadi et al., 2018). In Nigeria, unlike the UK, there is lack of well-developed nationalised screening programs, lack of emergency services, inadequate presence of the multi-disciplinary team and undeveloped healthcare system. These are acting as weakness for CVD management in the country as without wider screening effective diagnosis for CVD in affected individuals cannot be made leading to failure of healthcare reach to them which contributes to their slow death (Keates et al., 2017). Moreover, lack multi-disciplinary approach makes patients devoid of holistic care and underdevelop healthcare system along with lack of emergency services leads worsened control of sudden cardiac issues such as stroke in people leading individuals to suffer from hindered health and well-being (Mocumbi, 2012). In Nigeria, the opportunities for CVD management include financial support from WHO, increased recruitment of educated healthcare staffs, new introduction of advanced care measures for CVD and enhanced healthcare policy-making with support from international healthcare agencies and high-income countries (WHO, 2019). This is evident as WHO is seen to contribute increased finances for Nigeria for improving CVD management are showing to work together in curbing CVD from the country (WHO, 2019). This is effective opportunity to resolve financial issues and create use of money to update the CVD care services for delivering enhanced support to patients in Nigeria. In addition, support from international agencies like WHO and high-income countries is helping Nigeria to develop well-develop care environment for CVD management which is a key opportunity as it would act in lowering the increased delay in care for CVD and unnecessary deaths among patients by creating delivery of timely strategic care (WHO, 2019). The existing threats regarding CVD in Nigeria are increased rise of patients with CVD, lack of enhanced awareness for CVD management, poor health and lifestyle condition. It is evident as lack of effective health awareness to develop healthy behaviour needed for avoiding CVD and its effective management has led 11% of people in the country died from disease (WHO, 2019; Ike and Onyema, 2020). Moreover, it is reported that poor lifestyle such as increased fats food, low physical exercise and others promoted CVD development in the country as they contribute to hindered control of hormones and nutrients level in the body, in turn creating body condition that is risky for worsened CVD conditions (Ike and Onyema, 2020).

Continue your journey with our comprehensive guide to Type-2 Diabetes Management in Elderly.

References

Amadi, C.E., Lawal, F.O., Mbakwem, A.C., Ajuluchukwu, J.N. and Oke, D.A., 2018. Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study. International journal of clinical pharmacy, 40(6), pp.1587-1595.

Hendriks, M.E., Bolarinwa, O.A., Wit, F.W., Brewster, L.M., Odusola, A.O., Rosendaal, N.T., Bindraban, N.R., Adenusi, P., Agbede, K., Lange, J.M. and Akande, T.M., 2015. Feasibility and quality of cardiovascular disease prevention within a community-based health insurance program in rural Nigeria: an operational cohort study. Journal of hypertension, 33(2), pp.366-375.

hmt-uk.org 2021, Cardiac Screening Supports British Cycling Policy, Available at: https://hmt-uk.org/news/hmt-cardiac-screening-supports-british-cycling-policy/#:~:text=The%20new%20policy%20means%20that,from%20academy%20to%20elite%20level. [Accessed on: 20 August 2021]

Ike, S.O. and Onyema, C.T., 2020. Cardiovascular diseases in Nigeria: What has happened in the past 20 years?. Nigerian Journal of Cardiology, 17(1), p.21.

Keates, A.K., Mocumbi, A.O., Ntsekhe, M., Sliwa, K. and Stewart, S., 2017. Cardiovascular disease in Africa: epidemiological profile and challenges. Nature Reviews Cardiology, 14(5), pp.273-293.

Mocumbi, A.O., 2012. Lack of focus on cardiovascular disease in sub-Saharan Africa. Cardiovascular diagnosis and therapy, 2(1), p.74.

Morton, G., Masters, J. and Cowburn, P.J., 2018. Multidisciplinary team approach to heart failure management. Heart, 104(16), pp.1376-1382.

NHS 2017, Cardiovascular Disease, Available at: https://publichealthmatters.blog.gov.uk/2017/09/29/how-are-we-working-together-to-tackle-cardiovascular-disease/ [Accessed on: 20 August 2021]

NHS 2019, Cardiovascular Disease, Available at: https://www.longtermplan.nhs.uk/online-version/chapter-3-further-progress-on-care-quality-and-outcomes/better-care-for-major-health-conditions/cardiovascular-disease/#:~:text=The%20NHS%20will%20help%20prevent,out%20of%20hospital%20cardiac%20arrest. [Accessed on: 20 August 2021]

NHS 2021, Cardiovascular Disease, Available at: https://www.nhs.uk/conditions/coronary-heart-disease/treatment/ [Accessed on: 20 August 2021]

NICE 2019, Cardiovascular Disease, Available at: https://pathways.nice.org.uk/pathways/cardiovascular-disease-prevention [Accessed on: 20 August 2021]

Oluyombo, R., Akinwusi, P.O., Olamoyegun, M.A., Ayodele, O.E., Fawale, M.B., Okunola, O.O., Olanrewaju, T.O. and Akinsola, A., 2016. Clustering of cardiovascular risk factors in semi-urban communities in south-western Nigeria. Cardiovascular journal of Africa, 27(5), pp.322-327.

Petersen, S.E., Matthews, P.M., Francis, J.M., Robson, M.D., Zemrak, F., Boubertakh, R., Young, A.A., Hudson, S., Weale, P., Garratt, S. and Collins, R., 2015. UK Biobank’s cardiovascular magnetic resonance protocol. Journal of cardiovascular magnetic resonance, 18(1), pp.1-7.

Raisi-Estabragh, Z. and Petersen, S.E., 2020. Cardiovascular research highlights from the UK Biobank: opportunities and challenges. Cardiovascular research, 116(1), pp.e12-e15.

Said, M.A., Verweij, N. and van der Harst, P., 2018. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study. JAMA cardiology, 3(8), pp.693-702.

WHO 2019, WHO and Nigerian Government move to curb cardiovascular diseases, Available https://www.afro.who.int/news/who-and-nigerian-government-move-curb-cardiovascular-diseases [Accessed on: 20 August 2021]